Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Dorca Fontanez Santiago

General Practice San Juan, PR Physician Assistant

NPI 1346968112 CMS profile 11355740

525 Calle Francia Apt 603, San Juan, PR 00917

Open in the dashboard

General payments

$2,313

85 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dorca Fontanez Santiago of San Juan, PR is reported in the CMS Open Payments database as having received $2,313 across 85 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,175 46
2024 General $853 26
2023 General $244 11
2022 General $22 1
2021 General $20 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dorca Fontanez Santiago
  • General Practice median
  • Middle half of General Practice
  • National median

In program year 2025, general payments to Dorca Fontanez Santiago were reported at $1,175. Among 4,774 General Practice profiles paid that year, the median was $106 and the middle half received between $35 and $292.

Show as a table
Year Dorca Fontanez Santiago General Practice median Middle half National median
2019 $0 $107 $37–$285 $163
2020 $0 $75 $25–$213 $114
2021 $20 $93 $30–$272 $132
2022 $22 $103 $36–$279 $149
2023 $244 $106 $34–$276 $160
2024 $853 $114 $39–$290 $164
2025 $1,175 $106 $35–$292 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Eli Lilly Export S.A. Puerto Rico Branch $643 19 payments
  2. Janssen Pharmaceuticals, Inc $300 14 payments
  3. Genentech USA, Inc. $296 14 payments
  4. AbbVie, Inc. $282 12 payments
  5. Caris MPI, Inc. $204 4 payments
  6. AstraZeneca Pharmaceuticals LP $111 5 payments
  7. Amgen Inc. $94 1 payment
  8. Incyte Corporation $89 4 payments
  9. ADC Therapeutics America, Inc. $50 2 payments
  10. Puma Biotechnology, Inc. $48 2 payments
  11. Other $196 8 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,075 84 payments
  2. Education $238 1 payment
Products named General payments · program years 2021–2025
  1. VERZENIO $383 17 payments
  2. JAYPIRCA $338 15 payments
  3. VENCLEXTA $214 9 payments
  4. MI CANCER SEEK $204 4 payments
  5. RETEVMO $191 8 payments
  6. DARZALEX $173 8 payments
  7. POLIVY $146 7 payments
  8. ENHERTU $111 5 payments
  9. Kyprolis $94 1 payment
  10. Itovebi $92 4 payments
  11. Other $1,210 54 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other General Practice in Puerto Rico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record